New Zealand Orthopedic Physician, Dr. Zaid Matti, Visits San Diego Orthobiologics Medical Group To Observe Innovative Procedures
We had the pleasure of having New Zealand physician, Dr. Matti visit our medical clinic. Dr Matti was able to observe our innovative treatments for patients with joint arthritis and low back pain. We had great discussions about platelet rich plasma, bone marrow concentrate and adipose derived cell therapies and how together we can move the field of Regenerative Medicine forward. Thank you, Dr. Matti, for your visit and sharing your insights with us!
Dr Mary Ambach as Guest Speaker for The Doctor’s Hour.
The Doctor’s Hour is a program for doctors to access resources and videos from experts in the pain management and regenerative medicine field. Dr Ambach shared her expertise with colleagues on the current evidence of stem cell therapies for joint pain, osteoarthritis and tendon injuries.
Dr. Ramon Llull and Dr. Chris Rogers
Dr. Rogers met and collaborated with thought leaders in the Annual Conference of The San Diego Academy of Regenerative Therapies (SDARTs) from August 2-4 in San Diego, CA. The annual SDARTs conference together pioneers and experts in regenerative medicine and offers training on many different applications of regenerative medicine across different medical specialty fields. At San Diego Orthobiolgoics Medical Group, we continue to learn innovative procedures to find the best treatment options for our patients!
Dr. Christopher Rogers and Dr. Mary Ambach are proud to announce that San Diego Orthobiologics Medical Group is leading a multi-center clinical trial for the treatment of knee osteoarthritis. Click for details. https://personalizedstemcells.com
Dr. Christopher Rogers and Dr. Mary Ambach from the San Diego Orthobiologics Medical Group are one of only 10 sites treating patients in a multi-center clinical trial for the treatment of knee osteoarthritis using a patient’s own fat-derived stem cells. Personalized Stem Cells, Inc is sponsoring the FDA approved clinical trial, which is the FIRST EVER in the United States to study the use of a patient’s own fat-derived stem cells processed and tested in a centralized FDA inspected manufacturing lab. In addition to treating knee osteoarthritis, the patient’s stem cells may be stored in this facility and potentially used for the treatment of other medical conditions in future approved clinical trials.
Information about the clinical trial can be found here.
Check for updates regarding the study and the recruitment process on our website, SDOMG.com